ATLASATLAS fair value
ATLAS has no fair value for this stock today.
NexGel (NXGL)
NexGel stock price today, ATLAS forecast and fair value
Healthcare · Medical Instruments & Supplies · NASDAQ
$4.24▲ +7.07%
Prices as of Oct 27, 2026 · USD
Chance of rising in 1 month
39%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on NexGel in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On NexGel
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives NexGel a 39% chance of finishing higher a month from now (21 trading sessions) than today: somewhat worse than a coin flip.
In half of the simulated outcomes the price ends between $2.78 and $5.07; in 9 out of 10, between $1.63 and $8.66. Estimated annual volatility is 196%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- $1.7M
- 52-week high
- $53.60
- 52-week low
- $3.00
- Revenue (12 months)
- $12.1M
- Revenue growth (YoY)
- +31.5%
- Gross margin
- 39.5%
- Operating margin
- -29.3%
- Net margin
- -25.3%
- Return on equity
- -115.1%
- Free cash flow (12 months)
- $8.4M
- Beta
- 0.75
What this means
ATLAS does not publish a fair value for NXGL right now, but it does show its odds of rising: somewhat worse than a coin flip.
Over the last 52 weeks NXGL has traded between $3.00 and $53.60. Today it is 92.1% below that high and 41% above its low.
On the business: revenue grew 31.5% year over year; net margin is 25.3%.
Its beta is 0.75: it tends to move less than the market.
About the company
NexGel Inc. is a healthcare and consumer products company that develops and manufactures high-water-content hydrogels and gel-based formulations for wound care, medical diagnostics, transdermal drug delivery, cosmetics, and over-the-counter remedies.
Want to see everything about NexGel?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does NexGel do?
NexGel Inc. is a healthcare and consumer products company that develops and manufactures high-water-content hydrogels and gel-based formulations for wound care, medical diagnostics, transdermal drug delivery, cosmetics, and over-the-counter remedies.
What is the chance NXGL goes up next month?
39%: somewhat worse than a coin flip. In half of the simulated outcomes, NXGL ends the month between $2.78 and $5.07.
How big is NexGel and what is its P/E ratio?
NexGel's market capitalization is $1.7M. We do not show a P/E because it has no positive earnings to base one on.
How volatile is NXGL?
ATLAS estimates annual volatility at 196%. In a typical month, half of the outcomes end between $2.78 and $5.07.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer